Skip Navigation


JAC Advance Access originally published online on March 13, 2003
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
51/4/865    most recent
dkg156v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (20)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Stock, I.
Right arrow Articles by Wiedemann, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stock, I.
Right arrow Articles by Wiedemann, B.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


Journal of Antimicrobial Chemotherapy (2003) 51, 865-885
© 2003 The British Society for Antimicrobial Chemotherapy

Natural antimicrobial susceptibilities of strains of ‘unusual’ Serratia species: S. ficaria, S. fonticola, S. odorifera, S. plymuthica and S. rubidaea

Ingo Stock1,*, Sonja Burak1, Kimberley Jane Sherwood1, Thomas Grüger2 and Bernd Wiedemann1

1 Institut für Medizinische Mikrobiologie und Immunologie, Pharmazeutische Mikrobiologie, Meckenheimer Allee 168, University of Bonn, D-53115 Bonn; 2 Institut für Pharmazeutische Biologie und Mikrobiologie, Bundesstrasse 45, University of Hamburg, D-20146 Hamburg, Germany

Received 2 April 2002; returned 8 August 2002; revised 30 December 2002; accepted 13 January 2003

The natural susceptibility to 71 antibiotics of 104 Serratia strains of Serratia ficaria (n = 15), Serratia fonticola (n = 18), Serratia odorifera (n = 16), Serratia plymuthica (n = 32) and Serratia rubidaea (n = 23) was examined. MICs were determined using a microdilution procedure in IsoSensitest broth for all the strains and in cation-adjusted Mueller–Hinton broth for some strains. With few exceptions, all species tested were uniformly naturally resistant to penicillin G, oxacillin, cefazolin, cefuroxime, all tested macrolides, lincosamides, streptogramins, glycopeptides, fusidic acid and rifampicin, and naturally sensitive to several aminoglycosides, piperacillin, piperacillin/tazobactam, carbapenems, some cephalosporins, fluoroquinolones and folate-pathway inhibitors. Major species-related differences in natural susceptibility affecting clinical assessment criteria were seen with tetracyclines, some aminoglycosides, aminopenicillins, ticarcillin, cefaclor, loracarbef, cefoxitin, pipemidic acid, chloramphenicol, nitrofurantoin and fosfomycin. Differences in susceptibility dependent on the medium were seen with macrolides, tetracycline, fosfomycin and some ß-lactams. The natural antibiotic susceptibility patterns suggest novel species-specific mechanisms of antibiotic resistance. Uncharacterized species-specific aminoglycoside-modifying enzymes and multidrug efflux systems affecting tetracyclines, quinolones and chloramphenicol are probably responsible for some of the phenotypes observed. The natural amoxicillin sensitivity of several strains of some species combined with natural resistance to some narrow-spectrum cephalosporins indicate the expression of naturally occurring ß-lactamases with unique substrate profiles. ß-Lactamases of representative strains of each species were characterized phenotypically and genotypically. It was shown that all species expressed naturally occurring AmpC ß-lactamases and, with respect to S. fonticola, also a species-specific class A ß-lactamase. Inducibility of these enzymes was shown in all species with the exception of S. rubidaea and four of five strains of S. plymuthica.

* Corresponding author. Tel: +49-228-732114; Fax: +49-228-735267; E-mail: Ingo_Stock{at}web.de


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Clin. Microbiol. Rev.Home page
G. A. Jacoby
AmpC {beta}-Lactamases
Clin. Microbiol. Rev., January 1, 2009; 22(1): 161 - 182.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
F. Fonseca, A. C. Sarmento, I. Henriques, B. Samyn, J. van Beeumen, P. Domingues, M. R. Domingues, M. J. Saavedra, and A. Correia
Biochemical Characterization of SFC-1, a Class A Carbapenem-Hydrolyzing {beta}-Lactamase
Antimicrob. Agents Chemother., December 1, 2007; 51(12): 4512 - 4514.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
K. Kadlec, I. Wiegand, C. Kehrenberg, and S. Schwarz
Studies on the mechanisms of {beta}-lactam resistance in Bordetella bronchiseptica
J. Antimicrob. Chemother., March 1, 2007; 59(3): 396 - 402.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
I. Henriques, A. Moura, A. Alves, M. J. Saavedra, and A. Correia
Molecular Characterization of a Carbapenem-Hydrolyzing Class A {beta}-Lactamase, SFC-1, from Serratia fonticola UTAD54
Antimicrob. Agents Chemother., June 1, 2004; 48(6): 2321 - 2324.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.